Skip to main content
NeuronFeed

Galvanize Therapeutics · Series D

Designing pulsed electric field energy devices to unlock the body's natural responses for disease treatment and function restoration.

Amount

$130M

Round

Series D

Valuation

—

Announced

May 2023

Investors

Lead investor

HealthQuest Capital

Notes

auto-discovered via firecrawl

📎 Source